14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 3 days ( -17.60 % )
Last Price $3.14 5.72 %
High/ Low $2.97 - $3.19 24.92%
Chg 7 Days 27.13 % $2.47 $3.14
Chg 30 Days 6.80 % $2.94 $3.14
Chg 12 mos -15.14 % $3.70 $3.14
Trend - 3 mos -31.68 % Width: 57.38 %
Trend - 12 mos -14.26 % Width: 138.54 %
Pred. range - 3 mos $1.36 - $2.15 -56.59 % - -31.68 %
Pred. range - 12 mos $1.53 - $3.65 -51.30 % - 16.18 %
Short MA avg 3 mos Buy Apr 19, 2024 - 11 days
Long MA avg 3 mos Buy Apr 30, 2024 - 4 days
Short/Long MA avg 3 mos Buy May 01, 2024 - 3 days
Short MA avg 12 mos Buy Apr 26, 2024 - 6 days
Long MA avg 12 mos Sell Mar 06, 2024 - 42 days
Short/Long MA avg 12 mos Sell Mar 14, 2024 - 36 days
Pivot Short Buy Apr 19, 2024 - 11 days
Bollinger Buy Mar 08, 2024 - 40 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About MDxHealth SA

MDxHealth SA MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use ... MDXH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT